Table 2 Clinical characteristics of AD patients on observation at ALERT comprehensive specialized hospital, dermatovenerology unit, addis Ababa, Ethiopia, from September 01, 2022 to February 28, 2023 (n = 403)

Types of Atopy

Pure AD

Mixed AD

341 (84.6%)

62 (15.4%)

1.15 ± 0.361

Duration of AD ( Years)

< 5Years ≥ 5 Years

308 (76.4%)

95 (23.6%)

2.235 ± 0.424

Age at onset of AD diagnosis (Years)

Early onset

Mid onset

Late onset

153 (38.0%)

168 (41.7%)

82 (20.3%)

4.785 ± 3.85

1–16

Current AD phase

Acute phase

Sub- Acute phase

Chronic phase

104 (25.8%)

170 (42.2%)

129 (32.0%)

AD characteristics

Lesional type

Non lessional type

114 (28.3%)

289 (71.7%)

AD severity categories (SCORAD)

Mild (0–14)

Moderate (15–40)

Sever (> 40)

145(36.0%)

232(57.6%)

26 (6.5%)

20.20 ± 10.63

1.90–56.30

Affected body parts

Flexural surfaces of extremities

Extensor surfaces of extremities

Face (forehead, cheeks, chin)

Mixed body site

99 (24.6%)

66 (16.4%)

56 (13.9%)

182 (45.2%)

Number of Family Positive for atopy

One of the parents

Both parents

None

112 (27.8%)

9 (2.2%)

282 (70%)

Positive Family history atopy

Atopic eczema Allergic rhinitis Bronchial asthma

Negative family history of atopy

29 (7.2%)

25 (6.2%)

67 (16.6%)

282(70.0%)

Patient Co-morbidity

Respiratory

Non-respiratory

No-comorbidity

53

15

335

13.2

3.7

83.1

Medical illness history of caregiver

HIV/AIDS

Asthma

Epilepsy

Hypertension

Diabetic mellitus

Others*

No history of medical illness

2 (0.5%)

51(12.7%)

0 (0%)

15 (3.7%)

5 (1.2%)

7 (1.7%)

323 (80.1%)